These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 410099)

  • 1. [Hypoglycemic sulfonylurea metabolites: clinical interest. Experiences with glibenclamide in the rat].
    Samimi H; Loutan L; Balant L; Tillolès M; Fabre J
    Schweiz Med Wochenschr; 1977 Sep; 107(37):1291-6. PubMed ID: 410099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolites of hypoglycemic sulfonylureas in kidney failure. Experience with glibenclamide].
    Loutan L; Samimi H; Balant L; Favre H; Fabre J
    Schweiz Med Wochenschr; 1978 Nov; 108(45):1782-6. PubMed ID: 100879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Des 4-trans-hydroxy-glibenclamide show hypoglycemic activity?
    Balant L; Fabre J; Loutan L; Samimi H
    Arzneimittelforschung; 1979; 29(1):162-3. PubMed ID: 109099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study.
    Rave K; Flesch S; Kühn-Velten WN; Hompesch BC; Heinemann L; Heise T
    Diabetes Metab Res Rev; 2005; 21(5):459-64. PubMed ID: 15915547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of sulfonylurea agents in older diabetic patients.
    Peters AL; Davidson MB
    Clin Geriatr Med; 1990 Nov; 6(4):903-21. PubMed ID: 2224754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers.
    Kirchheiner J; Brockmöller J; Meineke I; Bauer S; Rohde W; Meisel C; Roots I
    Clin Pharmacol Ther; 2002 Apr; 71(4):286-96. PubMed ID: 11956512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The radioimmunological determination of glibenclamide and its metabolites in serum.
    Glogner P; Heni N; Nissen L
    Arzneimittelforschung; 1977; 27(9):1703-7. PubMed ID: 411501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capillary electrophoretic detection of metabolites in the urine of patients receiving hypoglycemic drug therapy.
    Roche ME; Oda RP; Lawson GM; Landers JP
    Electrophoresis; 1997 Sep; 18(10):1865-74. PubMed ID: 9372282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible antidiabetic and antihyperlipidaemic effect of fermented Parkia biglobosa (JACQ) extract in alloxan-induced diabetic rats.
    Odetola AA; Akinloye O; Egunjobi C; Adekunle WA; Ayoola AO
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):808-12. PubMed ID: 16922811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of cyclosporine A on the activity of oral hypoglycemic agents in rats.
    Pollock SH; Reichbaum MI; Collier BH; D'Souza MJ
    J Pharmacol Exp Ther; 1991 Jul; 258(1):8-12. PubMed ID: 1906541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uniform elimination pattern for glibenclamide in healthy Caucasian males.
    Spraul M; Streeck A; Nieradzik M; Berger M
    Arzneimittelforschung; 1989 Nov; 39(11):1449-50. PubMed ID: 2515863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
    Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic activity and toxicity of Zizyphus spina-christi leaves.
    Abdel-Zaher AO; Salim SY; Assaf MH; Abdel-Hady RH
    J Ethnopharmacol; 2005 Oct; 101(1-3):129-38. PubMed ID: 16009520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential hypoglycemic effects of Chlorella in streptozotocin-induced diabetic mice.
    Jong-Yuh C; Mei-Fen S
    Life Sci; 2005 Jul; 77(9):980-90. PubMed ID: 15964314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glibenclamide in insulin-treated diabetic patients with a residual insulin secretion.
    Mauerhoff T; Ketelslegers JM; Lambert AE
    Diabete Metab; 1986 Feb; 12(1):34-8. PubMed ID: 3084315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorpropamide and glibenclamide serum concentrations in hospitalized patients.
    Huupponen R; Viikari J; Saarimaa H
    Ann Clin Res; 1982 Jun; 14(3):119-22. PubMed ID: 6814340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.